Cargando…

A Long-Term Survivor With Alveolar Capillary Dysplasia

A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yost, Chandler E., Putnam, Angelica R., Dishop, Megan K., Jorgensen, Lynda O., Wirkus, Paul E., Day, Ronald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302120/
https://www.ncbi.nlm.nih.gov/pubmed/34317003
http://dx.doi.org/10.1016/j.jaccas.2020.05.055
_version_ 1783726826923753472
author Yost, Chandler E.
Putnam, Angelica R.
Dishop, Megan K.
Jorgensen, Lynda O.
Wirkus, Paul E.
Day, Ronald W.
author_facet Yost, Chandler E.
Putnam, Angelica R.
Dishop, Megan K.
Jorgensen, Lynda O.
Wirkus, Paul E.
Day, Ronald W.
author_sort Yost, Chandler E.
collection PubMed
description A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering pulmonary arterial pressure and managing right heart failure. (Level of Difficulty: Beginner.)
format Online
Article
Text
id pubmed-8302120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83021202021-07-26 A Long-Term Survivor With Alveolar Capillary Dysplasia Yost, Chandler E. Putnam, Angelica R. Dishop, Megan K. Jorgensen, Lynda O. Wirkus, Paul E. Day, Ronald W. JACC Case Rep Mini-Focus Issue: Heart Failure A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering pulmonary arterial pressure and managing right heart failure. (Level of Difficulty: Beginner.) Elsevier 2020-07-29 /pmc/articles/PMC8302120/ /pubmed/34317003 http://dx.doi.org/10.1016/j.jaccas.2020.05.055 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Focus Issue: Heart Failure
Yost, Chandler E.
Putnam, Angelica R.
Dishop, Megan K.
Jorgensen, Lynda O.
Wirkus, Paul E.
Day, Ronald W.
A Long-Term Survivor With Alveolar Capillary Dysplasia
title A Long-Term Survivor With Alveolar Capillary Dysplasia
title_full A Long-Term Survivor With Alveolar Capillary Dysplasia
title_fullStr A Long-Term Survivor With Alveolar Capillary Dysplasia
title_full_unstemmed A Long-Term Survivor With Alveolar Capillary Dysplasia
title_short A Long-Term Survivor With Alveolar Capillary Dysplasia
title_sort long-term survivor with alveolar capillary dysplasia
topic Mini-Focus Issue: Heart Failure
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302120/
https://www.ncbi.nlm.nih.gov/pubmed/34317003
http://dx.doi.org/10.1016/j.jaccas.2020.05.055
work_keys_str_mv AT yostchandlere alongtermsurvivorwithalveolarcapillarydysplasia
AT putnamangelicar alongtermsurvivorwithalveolarcapillarydysplasia
AT dishopmegank alongtermsurvivorwithalveolarcapillarydysplasia
AT jorgensenlyndao alongtermsurvivorwithalveolarcapillarydysplasia
AT wirkuspaule alongtermsurvivorwithalveolarcapillarydysplasia
AT dayronaldw alongtermsurvivorwithalveolarcapillarydysplasia
AT yostchandlere longtermsurvivorwithalveolarcapillarydysplasia
AT putnamangelicar longtermsurvivorwithalveolarcapillarydysplasia
AT dishopmegank longtermsurvivorwithalveolarcapillarydysplasia
AT jorgensenlyndao longtermsurvivorwithalveolarcapillarydysplasia
AT wirkuspaule longtermsurvivorwithalveolarcapillarydysplasia
AT dayronaldw longtermsurvivorwithalveolarcapillarydysplasia